| This article has been cited by |
| 1 | Incidence and Determinants of Piperacillin/Tazobactam-Associated Hypokalemia: A Retrospective Study | |
| Heenam Seo,Eunyoung Kim |
| Antibiotics.2022;11(8)1138 |
| [DOI] |
|
| 2 | Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study | |
| Saurabh Gupta,Syed A Zaki,Sanjeevani Masavkar,Preeti Shanbag |
| Cureus.2023;11(8)1138 |
| [DOI] |
|
| 3 | Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study | |
| Kimberly A. Toussaint,Jason C. Gallagher |
| Cureus.2014;35(8)447 |
| [DOI] |
|
| 4 | Torsade de Pointes Induced by Hypokalemia from Imipenem and Piperacillin | |
| Varun Kumar,Sandeep Khosla,Monica Stancu |
| Case Reports in Cardiology.2017;2017(8)1 |
| [DOI] |
|
| 5 | High anion gap metabolic acidosis caused by penicillin G: A case report | |
| Shizuka Nohara,Hiroyuki Akebo,Ryuichi Sada,Yukio Tsugihashi,Saki Minoda,Hirofumi Miyake,Hiroyasu Ishimaru,Kazuhiro Hatta |
| Tenri Medical Bulletin.2020;23(1)21 |
| [DOI] |
|
| 6 | Flucloxacillin-induced hypokalaemia: a case report | |
| Eva De Backer,Heidi Hannon |
| Acta Clinica Belgica.2018;73(6)435 |
| [DOI] |
|
| 7 | Flucloxacillin-induced hypokalaemia: a case report | |
| SANA F. KHAN,BRENDAN T. BOWMAN |
| Acta Clinica Belgica.2020;73(6)19 |
| [DOI] |
|
| 8 | Metabolic alkalosis: A less appreciated side effect of Imipenem-cilastin use-comment | |
| Preeti Shanbag |
| Indian Journal of Critical Care Medicine.2014;18(2)122 |
| [DOI] |
|
| 9 | Severe acute hypokalaemia associated with piperacillin/tazobactam in an HIV-infected patient under antiretroviral therapy with tenofovir alafenamide: case report and literature review | |
| Cheng-Chun Tai,Ruey-Yi Chou,Jiun-Yu Guo,Hsin-Pai Chen |
| Sexual Health.2020;17(2)194 |
| [DOI] |
|
| 10 | Metabolic alkalosis: A less appreciated side-effect of imipenem cilastatin use-author's reply | |
| Surya Kumar Dube,Suman Sarkar,P. S. Panda,D. K. Singh |
| Indian Journal of Critical Care Medicine.2014;18(6)406 |
| [DOI] |
|
| 11 | Antimicrobial Agents-induced Hypokalemia: A Possible Causality Association | |
| Harmeet Singh Rehan,Priyanka Hotha |
| Indian Journal of Critical Care Medicine.2019;23(4)175 |
| [DOI] |
|
| 12 | Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial | |
| Hossein Khalili,Hamid Rahmani,Mostafa Mohammadi,Mohamadreza Salehi,Zahra Mostafavi |
| DARU Journal of Pharmaceutical Sciences.2021;29(2)341 |
| [DOI] |
|
| 13 | Acute delirium following administration of Piperacillin-Tazobactam in an elderly patient with chronic liver disease | |
| R.G. Manappallil,U. Karadan,P. Kumar,M.C. Sabir,R.N. Supreeth |
| European Geriatric Medicine.2017;8(4)285 |
| [DOI] |
|
| 14 | Incidence and Risk Factors of Hypokalemia in Tazobactam/Piperacillin-administered Patients | |
| Hironobu Kuramoto,Sho Masago,Yuki Kashiwagi,Midori Maeda |
| YAKUGAKU ZASSHI.2019;139(12)1591 |
| [DOI] |
|
| 15 | Electrolyte Disorders Associated with Piperacillin/Tazobactam: A Pharmacovigilance Study Using the FAERS Database | |
| Heenam Seo,Eunyoung Kim |
| Antibiotics.2023;12(2)240 |
| [DOI] |
|
| 16 | Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia | |
| Charlotte D.C.C. Heijden,Marleen L. Duizer,Hanneke W.H.A. Fleuren,Bart A. Veldman,Tom Sprong,Anton T.S.M. Dofferhoff,Cornelis Kramers |
| British Journal of Clinical Pharmacology.2019;85(12)2886 |
| [DOI] |
|
| 17 | Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia | |
| Tolulope Rosanwo,Jennifer A. McArthur,Natasha Archer |
| British Journal of Clinical Pharmacology.2019;85(12)71 |
| [DOI] |
|
| 18 | Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia | |
| Kristen Bova Campbell |
| British Journal of Clinical Pharmacology.2022;85(12)231 |
| [DOI] |
|
